Article info
Letter
Risk of malignancy in patients treated for systemic necrotising vasculitis
- Correspondence to Dr Antoine Lafarge, Internal Medicine, Hopital Cochin, Paris 75014, France; antoinelafarge{at}outlook.com; Pr Benjamin Terrier; benjamin.terrier{at}aphp.fr
Citation
Risk of malignancy in patients treated for systemic necrotising vasculitis
Publication history
- Received October 9, 2019
- Revised November 12, 2019
- Accepted November 15, 2019
- First published November 25, 2019.
Online issue publication
February 12, 2020
Article Versions
- Previous version (25 November 2019).
- Previous version (13 December 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.